Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Bailly

Showing results (141-150 of 290) with videos related to

Pageof 29
Sort By:
Rapid Communications in Mass Spectrometry : RCM|April 21, 2025
HR-MS Analysis of the Covalent Binding of Edaravone to 5-Formylpyrimidine Bases and a DNA Oligonucleotide Containing a 5-Formylcytidine ResidueRomain Regnault, Mostafa Kouach, Laurence Goossens, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 27, 2005
Partial dewetting of polyethylene thin films on rough silicon dioxide surfacesFajun Zhang, Gabriel Baralia, Adrian Boborodea, et al.
Discovery Medicine|November 2, 2010
The next generation of antibody-drug conjugates comes of ageAlain Beck, Jean-François Haeuw, Thierry Wurch, et al.
Biochemical Pharmacology|September 20, 2011
Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase IIViviane Brel, Jean-Philippe Annereau, Stéphane Vispé, et al.
Biochemistry|May 21, 2003
Sequence-selective targeting of long stretches of the DNA minor groove by a novel dimeric bis-benzimidazoleAlexandra Joubert, Xiao-Wen Sun, Eric Johansson, et al.
Medecine Sciences : M/S|December 29, 2009
[The potential of monoclonal antibodies in cancer : established trastuzumab and cetuximab and promising targets IGF-1R and c-MET]Alexandre Bodmer, Liliane Goetsch, Laurence Favet, et al.
Cancers|July 27, 2022
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint InhibitorsXavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancer Letters|April 6, 2005
Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug effluxMarie Vanhuyse, Jérôme Kluza, Christèle Tardy, et al.
Journal of Medicinal Chemistry|March 7, 2003
4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agentsFranck Charmantray, Martine Demeunynck, Danièle Carrez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2003
Cytotoxicity and DNA binding properties of the plant alkaloid burasaineJérôme Kluza, Brigitte Baldeyrou, Pierre Colson, et al.
Pageof 29

Showing results (141-150 of 290) with videos related to

Sort By:
Pageof 29
Rapid Communications in Mass Spectrometry : RCM|April 21, 2025
HR-MS Analysis of the Covalent Binding of Edaravone to 5-Formylpyrimidine Bases and a DNA Oligonucleotide Containing a 5-Formylcytidine ResidueRomain Regnault, Mostafa Kouach, Laurence Goossens, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 27, 2005
Partial dewetting of polyethylene thin films on rough silicon dioxide surfacesFajun Zhang, Gabriel Baralia, Adrian Boborodea, et al.
Discovery Medicine|November 2, 2010
The next generation of antibody-drug conjugates comes of ageAlain Beck, Jean-François Haeuw, Thierry Wurch, et al.
Biochemical Pharmacology|September 20, 2011
Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase IIViviane Brel, Jean-Philippe Annereau, Stéphane Vispé, et al.
Biochemistry|May 21, 2003
Sequence-selective targeting of long stretches of the DNA minor groove by a novel dimeric bis-benzimidazoleAlexandra Joubert, Xiao-Wen Sun, Eric Johansson, et al.
Medecine Sciences : M/S|December 29, 2009
[The potential of monoclonal antibodies in cancer : established trastuzumab and cetuximab and promising targets IGF-1R and c-MET]Alexandre Bodmer, Liliane Goetsch, Laurence Favet, et al.
Cancers|July 27, 2022
Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint InhibitorsXavier Thuru, Romain Magnez, Hassiba El-Bouazzati, et al.
Cancer Letters|April 6, 2005
Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug effluxMarie Vanhuyse, Jérôme Kluza, Christèle Tardy, et al.
Journal of Medicinal Chemistry|March 7, 2003
4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agentsFranck Charmantray, Martine Demeunynck, Danièle Carrez, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2003
Cytotoxicity and DNA binding properties of the plant alkaloid burasaineJérôme Kluza, Brigitte Baldeyrou, Pierre Colson, et al.
Pageof 29